Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maintenance Dialysis Patients”

96 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 96 results

Not applicableStudy completedNCT03943212
What this trial is testing

The Effect of Blood Flow Rate on Dialysis Recovery Time in Patients Undergoing Maintenance Hemodialysis

Who this might be right for
ESRDFatigueHemodialysis-Induced Symptom
Satellite Healthcare 102
Testing effectiveness (Phase 2)Study completedNCT00228449
What this trial is testing

Peginesatide for Anemia in Chronic Hemodialysis Patients

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 165
Not applicableNo Longer AvailableNCT01892202
What this trial is testing

A Non-Interventional Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease Not on Dialysis

Who this might be right for
Anemia
Hoffmann-La Roche
Not applicableStudy completedNCT02185911
What this trial is testing

Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis

Who this might be right for
AnaemiaChronic Kidney Disease (CKD)
Amgen 308
Large-scale testing (Phase 3)Study completedNCT00642304
What this trial is testing

Subcutaneous C.E.R.A. for the Maintenance of Hemoglobin Levels in Participants With Chronic Renal Anemia Not on Dialysis.

Who this might be right for
Anemia
Hoffmann-La Roche 20
Large-scale testing (Phase 3)Study completedNCT00773968
What this trial is testing

Monthly Subcutaneous Continuous Erythropoietin Receptor Activator (CERA) in Predialysis Participants With Chronic Renal Anemia

Who this might be right for
Anemia
Hoffmann-La Roche 140
Large-scale testing (Phase 3)Study completedNCT01324128
What this trial is testing

Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients

Who this might be right for
Chronic Kidney Disease Requiring Chronic Dialysis
Vifor Pharma 1,059
Testing effectiveness (Phase 2)Study completedNCT00364832
What this trial is testing

Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.

Who this might be right for
Anemia
Hoffmann-La Roche 137
Post-approval studies (Phase 4)Study completedNCT06358820
What this trial is testing

Exploring the Effectiveness and Safety of Amino Acid Peritoneal Dialysis Solution

Who this might be right for
Exploring the Effectiveness and Safety of Amino Acid Peritoneal Dialysis Solution
The People's Hospital of Gaozhou 149
Large-scale testing (Phase 3)UnknownNCT04239391
What this trial is testing

Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)

Who this might be right for
End Stage Renal Disease
Rockwell Medical Technologies, Inc. 150
Not applicableLooking for participantsNCT05449067
What this trial is testing

Comparison of Efficacy Between Nighttime and Daytime Peritoneal Dialysis

Who this might be right for
End-Stage Kidney DiseasePeritoneal Dialysis
Nanfang Hospital, Southern Medical University 124
Large-scale testing (Phase 3)Ended earlyNCT00462384
What this trial is testing

Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Participants With Chronic Kidney Disease.

Who this might be right for
Anemia
Hoffmann-La Roche 39
Not applicableStudy completedNCT01213485
What this trial is testing

An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease on Dialysis (HORTENSIA)

Who this might be right for
Anemia
Hoffmann-La Roche 419
Not applicableLooking for participantsNCT06233838
What this trial is testing

Multi-center Clinical Study on Hemoperfusion of KHA80

Who this might be right for
UremiaUremic OsteodystrophyDialysis Related Complication
First Affiliated Hospital of Fujian Medical University 394
Testing effectiveness (Phase 2)Study completedNCT01958970
What this trial is testing

Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting

Who this might be right for
End Stage Renal DiseaseKidney DiseaseProtein Energy Wasting
Pinta Biotherapeutics 51
Large-scale testing (Phase 3)Study completedNCT00773331
What this trial is testing

A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia.

Who this might be right for
Anemia
Hoffmann-La Roche 281
Large-scale testing (Phase 3)Looking for participantsNCT07122401
What this trial is testing

Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism

Who this might be right for
Secondary Hyperparathyroidism, Chronic Kidney Disease
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 424
Post-approval studies (Phase 4)Study completedNCT00737464
What this trial is testing

Once Monthly Intravenous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.

Who this might be right for
Anemia
Hoffmann-La Roche 132
Not applicableStudy completedNCT02064153
What this trial is testing

Studying the Effect of Dialysate Temperature on Toxin Removal and Hypotension

Who this might be right for
Dialysis AmyloidosisHypotension
National University Hospital, Singapore 14
Not applicableStudy completedNCT07348913
What this trial is testing

Impact of Regular Low-Frequency Hemoperfusion on Medium- to Long-Term Prognosis in Maintenance Dialysis Patients

Who this might be right for
Regular Low-Frequency HemoperfusionMedium- to Long-Term PrognosisMaintenance Dialysis Patients+1 more
Yunfeng Xia 879
Load More Results